Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, announces that Robin Freestone is to join its Board as Non-Executive Director and member of the Audit Committee on 1 September 2015.
Roberto Quarta, Chairman of Smith & Nephew, commented:
“Robin is a well-regarded FTSE 100 CFO who has been heavily involved with the transformation and diversification of Pearson. He also has many years of experience in the healthcare industry at Amersham. He will be a valuable addition to our Board.”
Robin has been Chief Financial Officer of Pearson plc since 2006, and is retiring from this executive role on 1 August 2015. He will be joining the Board of Moneysupermarket.com Group PLC as Non-Executive Director on 1 August 2015.
Previously he was Deputy Chief Financial Officer at Pearson and prior to that, he held a number of senior financial positions at Amersham plc from 2000 to 2004, Henkel Ltd from 1995 to 2000 and ICI plc from 1984 to 1995. He started his career at Deloitte (Touche Ross).
He sits on the Board of ICAEW as an Advisory Group Member, Financial Reporting Faculty and is a member of the CBI Economic Growth Board and was a Non-Executive director of eChem Ltd from 2000 to 2014. He is currently Deputy Chair of the 100 Group, having been Chair from 2012 to 2014.
A British national, Robin holds a BA in Economics from Manchester University and is a Chartered Accountant.
No disclosure obligations arise under paragraphs (1) to (6) of LR 9.6.13 R of the UK Listing Authority’s Listing Rules in respect of this appointment. Mr Freestone’s fees will be £63,000 cash plus £3,500 in Smith & Nephew shares per annum, in-line with current Non-Executive Directors.
About Smith & Nephew
Smith & Nephew is a global medical technology business dedicated to helping healthcare professionals improve people’s lives. With leadership positions in Orthopaedic Reconstruction, Advanced Wound Management, Sports Medicine and Trauma & Extremities, Smith & Nephew has around 14,000 employees and a presence in more than 100 countries. Annual sales in 2014 were more than $4.6 billion. Smith & Nephew is a member of the FTSE100 (LSE: SN, NYSE: SNN).
For more information about Smith & Nephew, please visit our corporate website www.smith-nephew.com, follow @SmithNephewplc on Twitter or visit SmithNephewplc on Facebook.com.